Xylem Inc. (NYSE:XYL) declared a quarterly dividend on Thursday, October 13th. Stockholders of record on Wednesday, November 9th will be paid a dividend of 0.1549 per share on Wednesday, December 7th. This represents a $0.62 annualized dividend and a dividend yield of 1.25%.
Xylem (NYSE:XYL) opened at 49.66 on Friday. The stock has a 50 day moving average price of $50.93 and a 200 day moving average price of $46.39. Xylem has a one year low of $31.67 and a one year high of $53.25. The firm has a market cap of $8.90 billion, a PE ratio of 26.51 and a beta of 1.15.
Xylem (NYSE:XYL) last issued its quarterly earnings data on Tuesday, August 2nd. The company reported $0.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.47 by $0.01. The company had revenue of $932 million for the quarter, compared to analyst estimates of $927.69 million. Xylem had a return on equity of 16.41% and a net margin of 9.22%. The business’s quarterly revenue was up 1.3% compared to the same quarter last year. During the same quarter last year, the company posted $0.43 earnings per share. Equities research analysts expect that Xylem will post $2.04 EPS for the current year.
In other news, insider Tomas Brannemo sold 8,524 shares of Xylem stock in a transaction that occurred on Wednesday, August 17th. The shares were sold at an average price of $50.06, for a total transaction of $426,711.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Steven R. Loranger sold 33,887 shares of Xylem stock in a transaction that occurred on Thursday, August 11th. The shares were sold at an average price of $48.11, for a total transaction of $1,630,303.57. Following the sale, the director now owns 11,243 shares of the company’s stock, valued at $540,900.73. The disclosure for this sale can be found here. Insiders own 0.77% of the company’s stock.
Large investors have recently bought and sold shares of the stock. FMR LLC increased its stake in Xylem by 74.1% in the second quarter. FMR LLC now owns 5,956,085 shares of the company’s stock worth $265,940,000 after buying an additional 2,534,911 shares during the last quarter. Bessemer Group Inc. boosted its position in shares of Xylem by 43,570.6% in the second quarter. Bessemer Group Inc. now owns 1,593,977 shares of the company’s stock worth $71,171,000 after buying an additional 1,590,327 shares during the period. Janus Capital Management LLC boosted its position in shares of Xylem by 225.0% in the second quarter. Janus Capital Management LLC now owns 1,215,657 shares of the company’s stock worth $54,279,000 after buying an additional 841,565 shares during the period. American Century Companies Inc. boosted its position in shares of Xylem by 190.6% in the second quarter. American Century Companies Inc. now owns 1,161,281 shares of the company’s stock worth $51,851,000 after buying an additional 761,695 shares during the period. Finally, Riverhead Capital Management LLC boosted its position in shares of Xylem by 446.2% in the second quarter. Riverhead Capital Management LLC now owns 232,997 shares of the company’s stock worth $10,747,000 after buying an additional 190,339 shares during the period. Institutional investors own 84.70% of the company’s stock.
XYL has been the topic of several research reports. Oppenheimer Holdings Inc. reaffirmed an “outperform” rating and set a $52.00 price objective (up previously from $46.00) on shares of Xylem in a report on Monday, June 20th. Zacks Investment Research lowered Xylem from a “buy” rating to a “hold” rating in a report on Friday, July 15th. Barclays PLC raised their price target on Xylem from $39.00 to $45.00 and gave the stock an “equal weight” rating in a report on Monday, July 18th. Royal Bank Of Canada raised their price target on Xylem from $47.00 to $51.00 and gave the stock an “outperform” rating in a report on Tuesday, August 16th. Finally, RBC Capital Markets set a $51.00 price target on Xylem and gave the stock a “buy” rating in a report on Tuesday, August 16th. Nine equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $45.00.
Xylem Company Profile
Xylem Inc is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.